Rani Therapeutics Holdings (RANI) Return on Assets (2021 - 2025)
Historic Return on Assets for Rani Therapeutics Holdings (RANI) over the last 5 years, with Q3 2025 value amounting to 3.52%.
- Rani Therapeutics Holdings' Return on Assets fell 22600.0% to 3.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.52%, marking a year-over-year decrease of 22600.0%. This contributed to the annual value of 1.2% for FY2024, which is 3800.0% down from last year.
- Rani Therapeutics Holdings' Return on Assets amounted to 3.52% in Q3 2025, which was down 22600.0% from 2.55% recorded in Q2 2025.
- In the past 5 years, Rani Therapeutics Holdings' Return on Assets ranged from a high of 0.41% in Q4 2021 and a low of 3.52% during Q3 2025
- Its 5-year average for Return on Assets is 1.15%, with a median of 0.93% in 2023.
- As far as peak fluctuations go, Rani Therapeutics Holdings' Return on Assets tumbled by -1100bps in 2023, and later tumbled by -22600bps in 2025.
- Rani Therapeutics Holdings' Return on Assets (Quarter) stood at 0.41% in 2021, then plummeted by -44bps to 0.59% in 2022, then crashed by -80bps to 1.06% in 2023, then crashed by -33bps to 1.41% in 2024, then tumbled by -149bps to 3.52% in 2025.
- Its Return on Assets was 3.52% in Q3 2025, compared to 2.55% in Q2 2025 and 1.8% in Q1 2025.